التفاصيل البيبلوغرافية
| العنوان: |
Empirical antifungal therapy for health care-associated intra-abdominal infection: a retrospective, multicentre and comparative study. |
| المؤلفون: |
Mokart, Djamel, Boutaba, Mehdi, Servan, Luca, Bertrand, Benjamin, Baldesi, Olivier, Lefebvre, Laurent, Gonzalez, Frédéric, Bisbal, Magali, Pastene, Bruno, Duclos, Gary, Faucher, Marion, Zieleskiewicz, Laurent, Chow-Chine, Laurent, Sannini, Antoine, Boher, Jean Marie, Ronflé, Romain, Leone, Marc |
| المصدر: |
Annals of Intensive Care; 6/25/2024, Vol. 14 Issue 1, p1-13, 13p |
| مصطلحات موضوعية: |
ANTIFUNGAL agents, CROSS infection, CRITICALLY ill, PATIENTS, FISHER exact test, MULTIPLE regression analysis, INTRA-abdominal infections, TREATMENT effectiveness, RETROSPECTIVE studies, DESCRIPTIVE statistics, MANN Whitney U Test, CHI-squared test, INTENSIVE care units, MEDICAL records, ACQUISITION of data, RESEARCH, COMPARATIVE studies, CANDIDIASIS, OLD age |
| مستخلص: |
Background: Current guidelines recommend using antifungals for selected patients with health care-associated intra-abdominal infection (HC-IAI), but this recommendation is based on a weak evidence. This study aimed to assess the association between early empirical use of antifungals and outcomes in intensive care unit (ICU) adult patients requiring re-intervention after abdominal surgery. Methods: A retrospective, multicentre cohort study with overlap propensity score weighting was conducted in three ICUs located in three medical institutions in France. Patients treated with early empirical antifungals for HC-IAI after abdominal surgery were compared with controls who did not receive such antifungals. The primary endpoint was the death rate at 90 days, and the secondary endpoints were the death rate at 1 year and composite criteria evaluated at 30 days following the HC-IAI diagnosis, including the need for re-intervention, inappropriate antimicrobial therapy and death, whichever occurred first. Results: At 90 days, the death rate was significantly decreased in the patients treated with empirical antifungals compared with the control group (11.4% and 20.7%, respectively, p = 0.02). No differences were reported for the secondary outcomes. Conclusion: The use of early empirical antifungal therapy was associated with a decreased death rate at 90 days, with no effect on the death rate at 1 year, the death rate at 30 days, the rate of re-intervention, the need for drainage, and empirical antibiotic and antifungal therapy failure at 30 days. [ABSTRACT FROM AUTHOR] |
|
Copyright of Annals of Intensive Care is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder